date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Arsanis, Dynavax Technologies, Puma Biotechnology, Opko Health, Adaptimmune Therapeutics, and Codexis  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-22-18,Adaptimmune's stock tumbles after cancer study results prompts price target cut,MarketWatch
